Suppr超能文献

通过基于合同的私立优质医学协会减少医疗差错并进行侵权法改革。

Medical error reduction and tort reform through private, contractually-based quality medicine societies.

作者信息

MacCourt Duncan, Bernstein Joseph

机构信息

Department of Psychiatry, Division of Psychiatry and Law, University of Massachusetts Medical School, USA.

出版信息

Am J Law Med. 2009;35(4):505-61. doi: 10.1177/009885880903500402.

Abstract

The current medical malpractice system is broken. Many patients injured by malpractice are not compensated, whereas some patients who recover in tort have not suffered medical negligence; furthermore, the system's failures demoralize patients and physicians. But most importantly, the system perpetuates medical error because the adversarial nature of litigation induces a so-called "Culture of Silence" in physicians eager to shield themselves from liability. This silence leads to the pointless repetition of error, as the open discussion and analysis of the root causes of medical mistakes does not take place as fully as it should. In 1993, President Clinton's Task Force on National Health Care Reform considered a solution characterized by Enterprise Medical Liability (EML), Alternative Dispute Resolution (ADR), some limits on recovery for non-pecuniary damages (Caps), and offsets for collateral source recovery. Yet this list of ingredients did not include a strategy to surmount the difficulties associated with each element. Specifically, EML might be efficient, but none of the enterprises contemplated to assume responsibility, i.e., hospitals and payers, control physician behavior enough so that it would be fair to foist liability on them. Likewise, although ADR might be efficient, it will be resisted by individual litigants who perceive themselves as harmed by it. Finally, while limitations on collateral source recovery and damages might effectively reduce costs, patients and trial lawyers likely would not accept them without recompense. The task force also did not place error reduction at the center of malpractice tort reform -a logical and strategic error, in our view. In response, we propose a new system that employs the ingredients suggested by the task force but also addresses the problems with each. We also explicitly consider steps to rebuff the Culture of Silence and promote error reduction. We assert that patients would be better off with a system where physicians cede their implicit "right to remain silent", even if some injured patients will receive less than they do today. Likewise, physicians will be happier with a system that avoids blame-even if this system placed strict requirements for high quality care and disclosure of error. We therefore conceive of de facto trade between patients and physicians, a Pareto improvement, taking form via the establishment of "Societies of Quality Medicine." Physicians working within these societies would consent to onerous processes for disclosing, rectifying and preventing medical error. Patients would in turn contractually agree to assert their claims in arbitration and with limits on recovery. The role of plaintiffs' lawyers would be unchanged, but due to increased disclosure, discovery costs would diminish and the likelihood of prevailing will more than triple. This article examines the legal and policy issues surrounding the establishment of Societies of Quality Medicine, particularly the issues of contracting over liability, and outlines a means of overcoming the theoretical and practical difficulties with enterprise liability, alternative dispute resolution and the imposition of limits on recovery for non-pecuniary damages. We aim to build a welfare enhancing system that rebuffs the culture of silence and promotes error reduction, a system that is at the same time legally sound, fiscally prudent and politically possible.

摘要

当前的医疗事故责任制度已漏洞百出。许多因医疗事故而受伤的患者未得到赔偿,而一些通过侵权诉讼获得赔偿的患者其实并未遭受医疗过失;此外,该制度的失灵令患者和医生都士气受挫。但最为重要的是,该制度使医疗失误持续存在,因为诉讼的对抗性在急于规避责任的医生中催生了一种所谓的“沉默文化”。这种沉默导致失误毫无意义地反复出现,因为对医疗差错根本原因的公开讨论和分析未能充分展开。1993年,克林顿总统的全国医疗保健改革特别工作组考虑了一种解决方案,其特点包括企业医疗责任(EML)、替代性纠纷解决机制(ADR)、对非金钱损害赔偿(上限)的一些限制以及对间接来源赔偿的抵消。然而,这份方案清单并未包括克服与每个要素相关困难的策略。具体而言,企业医疗责任可能有效,但所设想的承担责任的企业,即医院和付款方,对医生行为的控制程度不足以使其公平地承担责任。同样,尽管替代性纠纷解决机制可能有效,但会遭到认为自身会因此受损的个别诉讼当事人的抵制。最后,虽然对间接来源赔偿和损害赔偿的限制可能有效降低成本,但患者和原告律师在没有补偿的情况下可能不会接受。特别工作组也没有将减少失误置于医疗事故侵权改革的核心——在我们看来,这是一个逻辑和战略上的错误。作为回应,我们提出一种新制度,它采用特别工作组建议的要素,但也解决了每个要素存在的问题。我们还明确考虑了抵制沉默文化并促进减少失误的措施。我们断言,对于患者来说,在一个医生放弃其隐含的“沉默权”的制度下会更好,即使一些受伤患者获得的赔偿会比现在少。同样,对于医生来说,在一个避免指责的制度下会更开心——即使这个制度对高质量医疗和错误披露提出了严格要求。因此,我们设想患者和医生之间进行事实上的交易,这是一种帕累托改进,通过建立“优质医疗协会”来实现。在这些协会中工作的医生将同意采用繁琐的程序来披露、纠正和预防医疗失误。患者则会通过合同约定同意在仲裁中主张自己的权利并接受赔偿限制。原告律师的角色不变,但由于披露增加,发现成本会降低,胜诉的可能性将增加两倍多。本文探讨了围绕建立优质医疗协会的法律和政策问题,特别是责任承包问题,并概述了一种克服企业责任、替代性纠纷解决机制以及对非金钱损害赔偿限制方面理论和实际困难的方法。我们旨在建立一个增强福利的制度,抵制沉默文化并促进减少失误,这个制度在法律上健全、财政上审慎且在政治上可行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验